Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen

Publisher： Karger

E-ISSN： 1421-9794|62|4|215-224

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.4, 2017-04, pp. : 215-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin

By  

Chemotherapy, Vol. 59, Iss. 6, 2014-07 ,pp. : 407-413

Karger

Access to resources Recommend Favorite

Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients

By  

Chemotherapy, Vol. 52, Iss. 4, 2006-06 ,pp. : 185-189

Karger

Access to resources Recommend Favorite

Comparison of Cisplatin-5-Fluorouracil-Folinic Acid versus Modified Docetaxel-Cisplatin-5-Fluorouracil Regimens in the First-Line Treatment of Metastatic Gastric Cancer

By  

Chemotherapy, Vol. 57, Iss. 3, 2011-05 ,pp. : 230-235

Karger

Access to resources Recommend Favorite

Advanced Gastric Cancer with Liver and Lymph Node Metastases Successfully Resected after Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 224-227

Karger

Access to resources Recommend Favorite

Epirubicin, Cisplatin and Continuous-Infusion 5-Fluorouracil (ECF Regimen) in the Treatment of Advanced Colorectal Cancer

By  

Chemotherapy, Vol. 47, Iss. 6, 2002-01 ,pp. : 438-443

Karger

Access to resources Recommend Favorite